Guoli Yi Email & Phone Number

Shanghai

 Led a team of 3 product managers to strategically cover 5 major areas of antifungal prevention and treatment, placing a specific focus on Hematology, and successfully completed brand strategy upgrades and transformation to align with VBP initiative. Strategically upgraded brand positioning, strategy, and value proposition for Noxafil, resulting in a successful replacement of departmental and portfolio strategies, with new SKU sales accounting for over 70% and a 20% penetration in restricted indications for medical insurance and self-paying patients, driving revenue growth and market penetration. Advanced pediatric indication CDE green channel approval in collaboration with Shanghai Medical Children Center, RA/RD/ME, and made Pre-launch Readiness preparations, positioning the brand for anticipated November 2024 approval, demonstrating successful pre-launch strategic planning and regulatory collaboration. Deployed a three-step VBP readiness product transformation strategy, including product strategy transformation, multi-channel expansion, and establishment of Post-VBP landing RAS model under VPS, driving strategic market positioning and readiness for Value-Based Procurement (VBP) regulations, showcasing advanced market adaptation strategies.

Halifax, Canada

 Spearheaded multi-channel marketing strategies and communications programs in China and North America, resulting in the successful leasing of 85 units and the facilitation of 4 real estate transactions, driving revenue and property acquisition within a 2-month period. Optimized company branding and marketing promotion strategies across 13 platforms, resulting in a 30% increase in new buyer acquisition and sales, demonstrating a keen understanding of digital marketing and revenue growth strategies. Conducted comprehensive market analysis, leveraging available market data to assist buyers and sellers in formulating profitable pricing strategies, resulting in a 15% increase in average property sales values and market competitiveness. Managed end-to-end property leasing operations for 124 properties, including detached houses, townhouses, and apartments, driving efficient tenant management and property occupancy rates. Successfully completed a month-long English-language course and achieved the highest score in the licensing exam on the first attempt, demonstrating a commitment to professional development and expertise in real estate regulations and practices. Operated a self-employed Limited company, leveraging in-depth knowledge of the housing market and professional real estate expertise to create a unique personal brand and label, enhancing market visibility and personal branding.

Shanghai

 Led the AMS team and collaborated with regional AMS managers to establish national platforms promoting the AB and AF product portfolio, driving the branding of AMS and optimizing external environments through innovative projects and partnerships with government departments. Developed innovative AMS strategies in collaboration with government departments to ensure product listing in hospital drug formularies and compliance with governmental education for clinicians, ensuring product availability and market access. Formulated unique tactics for the AB&AF market in coordination with NHMC and NMIA, creating antimicrobial drug management projects and policies to optimize the external environment for the anti-infective market, demonstrating strategic market development and collaboration skills. Established an internal taskforce team to provide training to cross-functional teams, enhancing internal influence and developing a standardized AMS model, resulting in heightened internal collaboration and concentration on AMS, driving strategic alignment and enhanced internal capabilities.

Shanghai

 Strategically led the pre-launch, launch, and post-launch branding of ZAVICEFTA®️, achieving a TTD of 24M USD and TTH of 16M USD (10.5M RMB), resulting in achieving the worldwide No.1 value position and maintaining No.1 SOV in the CR market, showcasing strong brand portfolio strategy and cross-functional leadership. Implemented research-based strategies leading to a 60% market share growth in ICU sales, establishing screening and new drug intervention projects in 300 key ICU centers, and exploring unique treatment approaches for specific patients, driving significant sales growth and market expansion. Improved resistance testing capabilities and popularized new diagnostic technologies, conducting comprehensive training in 300 core hospitals and establishing a CRE monitoring network, driving empirical treatment promotion and enhancing diagnostic capabilities, showcasing advanced technology implementation and market influence. Collaborated with KOLs and association leaders to update and write four ex

Shanghai

 Initiated the "REAL-Real world Experience Assessment Leading" CME program in collaboration with KOLs, combining online and offline modes to assess Chinese GPs' IFD perception and behavior data, resulting in the updating of the "Candidiasis Guidelines" and formulation of the "Consensus on Cryptococcosis in Zhejiang Province and Nationwide," positioning the brand as preferred for empirical treatment. Pioneered the "1+5" cryptococcal broad coverage conference model, engaging 1000 target customers HCPs across 25 cities and promoting the coverage of cryptococcal diagnostic methods, resulting in a 20% increase in positivity rate and an 18% sales increase (1.5 million RMB) for Diflucan, showcasing innovative market engagement strategies and significant sales impact. Developed the CHIFCoNET (China Invasive Fungi Collaborative Network) web and WeChat platform collaboration with NHC, engaging 35 national microbiology experts and introducing Microsoft's AI-based intelligent image recognition system, enhancing fu

Harbin/Xiamen/Quanzhou

1. Directed the sales strategy for 2 target products in Harbin and Xiamen & Quanzhou, driving market penetration and revenue growth in key regions.2. Implemented an organizational restructure, resulting in a significant improvement in management efficiency and operational effectiveness, streamlining processes and optimizing team performance.3. Managed and mentored 12 Sales Representatives, ensuring the team consistently met and exceeded sales targets, driving a culture of high performance and accountability.4. Established a talent retention and development system, leading to the promotion of 2 District Managers and 1 Brand Manager, showcasing a commitment to nurturing and advancing top talent within the organization.5. Attained the No.1 sales team status in the east region of Pfizer China, demonstrating exceptional leadership and strategic sales management, resulting in superior market performance and brand positioning.

Fuzhou, China

1. Drove sales performance for 2 products, consistently exceeding targets and driving market share growth, positioning the products as top performers in the national market.2. Recognized as a sales star nationally, demonstrating a consistent track record of exceptional sales performance and market impact, showcasing individual excellence and leadership within the sales team3. Achieved regional sales milestones, contributing to the overall growth and success of the sales team, and establishing a reputation for delivering results and exceeding expectations.